Antimicrobial Wound Dressings – Still Eligible for Reimbursement

With the GKV Contribution Rate Stabilization Act, adopted on July 10, 2026, the legal framework for wound care has been revised. Antimicrobial dressings – including silver-containing wound dressings – are explicitly covered by the new statutory definition of dressings (§ 31 (1a) SGB V). They therefore remain directly prescribable at the expense of statutory health insurance (GKV), including beyond the end of the transitional period for demonstrating medical benefit on December 31, 2026. No separate proof of benefit is required for these products.

Our wound dressings from the Zorflex range are not affected by the regulation; they are based on activated carbon fibers and therefore remain reimbursable as dressings.

What does this mean for you?

There is no change to the prescribability or reimbursement eligibility of our products! For you and your patients, this means continued security in terms of treatment and planning. You can continue to use and bill for the products supplied by us without any changes. No action is required on your part. Should the Federal Joint Committee (Gemeinsamer Bundesausschuss) publish product group lists in the future, we will inform you in good time. We thank you for your continued trust and cooperation and look forward to continuing to support you reliably with modern solutions for wound care.